vs

Side-by-side financial comparison of Capital Bancorp Inc (CBNK) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $62.7M, roughly 1.4× Capital Bancorp Inc). On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs 11.6%). Over the past eight quarters, Capital Bancorp Inc's revenue compounded faster (23.7% CAGR vs 23.4%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

CBNK vs EOLS — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.4× larger
EOLS
$90.3M
$62.7M
CBNK
Growing faster (revenue YoY)
EOLS
EOLS
+2.8% gap
EOLS
14.4%
11.6%
CBNK
Faster 2-yr revenue CAGR
CBNK
CBNK
Annualised
CBNK
23.7%
23.4%
EOLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBNK
CBNK
EOLS
EOLS
Revenue
$62.7M
$90.3M
Net Profit
$130.0K
Gross Margin
65.7%
Operating Margin
31.4%
4.7%
Net Margin
0.1%
Revenue YoY
11.6%
14.4%
Net Profit YoY
101.9%
EPS (diluted)
$0.92
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBNK
CBNK
EOLS
EOLS
Q4 25
$62.7M
$90.3M
Q3 25
$63.1M
$69.0M
Q2 25
$60.8M
$69.4M
Q1 25
$58.6M
$68.5M
Q4 24
$56.2M
$78.9M
Q3 24
$45.0M
$61.1M
Q2 24
$43.9M
$66.9M
Q1 24
$41.0M
$59.3M
Net Profit
CBNK
CBNK
EOLS
EOLS
Q4 25
$130.0K
Q3 25
$15.1M
$-15.7M
Q2 25
$13.1M
$-17.1M
Q1 25
$13.9M
$-18.9M
Q4 24
$-6.8M
Q3 24
$8.7M
$-19.2M
Q2 24
$8.2M
$-11.3M
Q1 24
$6.6M
$-13.1M
Gross Margin
CBNK
CBNK
EOLS
EOLS
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Q1 24
68.3%
Operating Margin
CBNK
CBNK
EOLS
EOLS
Q4 25
31.4%
4.7%
Q3 25
-1.5%
-16.7%
Q2 25
-1.5%
-14.7%
Q1 25
-1.5%
-22.1%
Q4 24
-2.2%
-2.9%
Q3 24
-2.2%
-25.3%
Q2 24
-1.8%
-11.5%
Q1 24
-2.3%
-15.0%
Net Margin
CBNK
CBNK
EOLS
EOLS
Q4 25
0.1%
Q3 25
23.9%
-22.8%
Q2 25
21.6%
-24.7%
Q1 25
23.8%
-27.6%
Q4 24
-8.6%
Q3 24
19.3%
-31.4%
Q2 24
18.7%
-17.0%
Q1 24
16.0%
-22.1%
EPS (diluted)
CBNK
CBNK
EOLS
EOLS
Q4 25
$0.92
$0.01
Q3 25
$0.89
$-0.24
Q2 25
$0.78
$-0.27
Q1 25
$0.82
$-0.30
Q4 24
$0.44
$-0.11
Q3 24
$0.62
$-0.30
Q2 24
$0.59
$-0.18
Q1 24
$0.47
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBNK
CBNK
EOLS
EOLS
Cash + ST InvestmentsLiquidity on hand
$53.8M
Total DebtLower is stronger
$146.1M
Stockholders' EquityBook value
$401.8M
$-23.1M
Total Assets
$3.6B
$225.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBNK
CBNK
EOLS
EOLS
Q4 25
$53.8M
Q3 25
$43.5M
Q2 25
$61.7M
Q1 25
$67.9M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$93.7M
Q1 24
$97.0M
Total Debt
CBNK
CBNK
EOLS
EOLS
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Q1 24
$120.6M
Stockholders' Equity
CBNK
CBNK
EOLS
EOLS
Q4 25
$401.8M
$-23.1M
Q3 25
$394.8M
$-28.8M
Q2 25
$380.0M
$-18.7M
Q1 25
$369.6M
$-6.6M
Q4 24
$355.1M
$5.5M
Q3 24
$280.1M
$5.9M
Q2 24
$267.9M
$19.3M
Q1 24
$259.5M
$18.4M
Total Assets
CBNK
CBNK
EOLS
EOLS
Q4 25
$3.6B
$225.9M
Q3 25
$3.4B
$219.0M
Q2 25
$3.4B
$228.8M
Q1 25
$3.3B
$213.4M
Q4 24
$3.2B
$232.6M
Q3 24
$2.6B
$229.6M
Q2 24
$2.4B
$233.8M
Q1 24
$2.3B
$226.2M
Debt / Equity
CBNK
CBNK
EOLS
EOLS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBNK
CBNK
EOLS
EOLS
Operating Cash FlowLast quarter
$69.7M
$12.8M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
12.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
98.67×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBNK
CBNK
EOLS
EOLS
Q4 25
$69.7M
$12.8M
Q3 25
$32.9M
$-14.7M
Q2 25
$-4.2M
$-24.8M
Q1 25
$22.6M
$-15.6M
Q4 24
$34.9M
$4.8M
Q3 24
$-464.0K
$-5.7M
Q2 24
$12.9M
$-6.5M
Q1 24
$-3.4M
$-10.6M
Free Cash Flow
CBNK
CBNK
EOLS
EOLS
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
Q1 24
$-10.9M
FCF Margin
CBNK
CBNK
EOLS
EOLS
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Q1 24
-18.3%
Capex Intensity
CBNK
CBNK
EOLS
EOLS
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Q1 24
0.4%
Cash Conversion
CBNK
CBNK
EOLS
EOLS
Q4 25
98.67×
Q3 25
2.18×
Q2 25
-0.32×
Q1 25
1.62×
Q4 24
Q3 24
-0.05×
Q2 24
1.57×
Q1 24
-0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons